申请人:SUNSHINE LAKE PHARMA CO., LTD.
公开号:US11396495B2
公开(公告)日:2022-07-26
An amine compound serving as a semicarbazide-sensitive amine oxidase (SSAO) and/or vascular adhesion protein-1 (VAP-1) inhibitor, a pharmaceutical composition, and an application thereof in medicines that can be used for treating inflammation and/or inflammation related diseases, diabetes and/or a disease related diabetes, psychiatric disorder, ischemic disease, vascular disease, fibrosis, or tissue transplant rejection.
一种可作为半咔嗪敏感胺氧化酶(SSAO)和/或血管粘附蛋白-1(VAP-1)抑制剂的胺化合物、一种药物组合物及其在药物中的应用,可用于治疗炎症和/或炎症相关疾病、糖尿病和/或糖尿病相关疾病、精神疾病、缺血性疾病、血管疾病、纤维化或组织移植排斥反应。